Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A randomized trial of genotype-guided perindopril use.

Journal of hypertension - 1 Nov 2023

Lee Sang-Hak, Lee Chan Joo, Kang Yura, Park Jung Mi, Lee Ji Hyun

Abstract excerpt

OBJECTIVE: Cough caused by angiotensin-converting enzyme inhibitors (ACEIs) limits their clinical application and cardiovascular benefits. This randomized trial investigated whether genotype-guided perindopril use could reduce drug-related cough in 20 to 79-year-old individuals with hypertension. METHODS: After screening 120 patients and randomization, 68 were assigned to genotyping ( n = 41) and control ( n...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Angiotensin-Converting Enzyme Inhibitors
Share to Cough

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genotype

Share to Hypertension

Share to Young Adult

Source

Identifiers

PMID: 37602458
DOI: 10.1097/HJH.0000000000003536

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A randomized trial of genotype-guided perindopril use.PMID 37602458Read ↗

Genome-wide association study of ACE inhibitor-induced cough implicates neuropeptides and shows genetic overlap with chronic dry coughSemantic proximity Read ↗

SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.Semantic proximity Read ↗

Genetic Variants Associated with Adverse Events after Angiotensin-Converting Enzyme Inhibitor Use: Replication after GWAS-Based Discovery.Semantic proximity Read ↗

A genome-wide association study identifies variants in KCNIP4 associated with ACE inhibitor-induced cough.Semantic proximity Read ↗

PNPT1 and PCGF3 variants associated with angiotensin-converting enzyme inhibitor-induced cough: a nested case-control genome-wide study.Semantic proximity Read ↗

Identification of genetic factors associated with susceptibility to angiotensin-converting enzyme inhibitors-induced cough.Semantic proximity Read ↗

Rs495828 polymorphism of the ABO gene is a predictor of enalapril-induced cough in Chinese patients with essential hypertensionSemantic proximity Read ↗

Individualized Angiotensin-Converting Enzyme (ACE)-Inhibitor Therapy in Stable Coronary Artery Disease Based on Clinical and Pharmacogenetic Determinants: The PERindopril GENEtic (PERGENE) Risk Model.Semantic proximity Read ↗

The rationale and design of the PERindopril GENEtic association study (PERGENE): a pharmacogenetic analysis of angiotensin-converting enzyme inhibitor therapy in patients with stable coronary artery disease.Semantic proximity Read ↗

Association between angiotensin-converting enzyme inhibitor-induced cough and the risk of lung cancer: a Mendelian randomization studySemantic proximity Read ↗

Pharmacogenetic predictors of development of secondary to enalapril dry cough in hypertensive patients.Semantic proximity Read ↗

Genetic determinants of treatment benefit of the angiotensin-converting enzyme-inhibitor perindopril in patients with stable coronary artery disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.